Evidence map›Paper›PMID 35368564›Full record

ArticleKidney3602022

Alian Al-Balas, Ammar Almehmi, Rakesh Varma, Hassan Al-Balas, Michael Allon

Open access · diamondAbstract read
In one paragraph

Article in Kidney360, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Observational
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. [Catheter Replacement Methods in Hemodialysis Patients With Dysfunctional Tunneled-Cuffed Catheters With Fibrin Sheaths].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2023
    Article
  12. Review
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Alian Al-BalasDivision of Nephrology, University of Alabama at Birmingham, Alabama.ORCID 0000-0002-6456-189X
Ammar AlmehmiDivision of Nephrology, University of Alabama at Birmingham, Alabama.ORCID 0000-0001-5988-4400
Rakesh VarmaDivision of Interventional Radiology, University of Alabama at Birmingham, Alabama.ORCID 0000-0001-9898-0059
Hassan Al-BalasDivision of Interventional Radiology, Baylor College of medicine, Houston, Texas.
Michael AllonDivision of Nephrology, University of Alabama at Birmingham, Alabama.
University of Alabama at Birmingham · USJordan University of Science and Technology · JO

Funding

Barriers to arteriovenous fistula use in black hemodialysis patientsR01MD013818 · NIMHD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ALLON, MICHAEL · 2019 to 2023
$2.3M
Endovascular vs. Surgical Arteriovenous Fistula OutcomesK23DK123319 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI AL-BALAS, ALIAN · 2020 to 2024
$911k
NIDDK NIH HHS K23 DK123319NIMHD NIH HHS R01 MD013818
6 · The paper itself

Abstract

Background: Central vein stenosis (CVS) is a common complication in hemodialysis patients following tunneled central venous catheter (CVC) insertion. Little is known about its incidence, association with patient characteristics, or relationship with duration of CVC placement. We systematically evaluated central vein stenosis in hemodialysis patients receiving their first CVC exchange at a large medical center. Methods: All new hemodialysis patients underwent an ultrasound before their internal jugular tunneled CVC placement, to exclude venous stenosis or thrombosis. After the initial CVC insertion, if the patients were referred for CVC exchange due to dysfunction, a catheterogram/venogram was performed to assess for hemodynamically significant (≥50%) central vein stenosis. During a 5-year period (January 2016 to January 2021), we quantified the incidence of CVS in patients undergoing CVC exchange. We also evaluated the association of central vein stenosis with patient demographics, comorbidities, and duration of CVC dependence before exchange. Results: During the study period, 273 patients underwent exchange of a tunneled internal jugular vein CVC preceded by a catheterogram/venogram. Hemodynamically significant CVS was observed in 36 patients (13%). CVS was not associated with patient age, sex, race, diabetes, hypertension, coronary artery disease, peripheral artery disease, or CVC laterality. However, the frequency of CVS was associated with the duration of CVC dependence (26% versus 11% for CVC duration ≥6 versus <6 months: odds ratio (95% CI), 3.17 (1.45 to 6.97), Conclusions: Among incident hemodialysis patients receiving their first tunneled internal jugular CVC exchange, the overall incidence of

Indexed as

Catheterization, Central VenousCentral Venous CathetersConstriction, PathologicHumansJugular VeinsRenal Dialysiscentral venous catheterscentral venous stenosisdialysispathologic constrictionrenal dialysistunneled catheter

Identifiers

PMID35368564
PMCPMC8967595
OpenAlexW3205273043

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.